Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

RWEal

Financiado

Real World Evidence RWE analytics to increase efficiency of clinical product d...

Medical product development is a lengthy and expensive process with limited success. After more than €40 million and over 10 years for clinical programmes, only 15% of new therapies reach the market. Many of the new therapies fail... ver más

31/12/2019

BENETE OY

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

BENETE OY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 4 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-12-31

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 6 años

0% 70% 100%

4 Participantes

BENETE OY

50.00K€ | Lider

AVI PAU ALIMENTACIO I CUINA...

PESQUERA ANPAJO

RIVEIRA PEIXE FRESCO

272.34K€ | Participante

Últimas noticias

30-11-2024: Cataluña Gestión For... Se ha cerrado la línea de ayuda pública: Gestión Forestal Sostenible para Inversiones Forestales Productivas para el organismo:

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

Duración del proyecto: 5 meses Fecha Inicio: 2019-07-11
Fecha Fin: 2019-12-31

Líder del proyecto

BENETE OY

TRL 4-5

Presupuesto del proyecto 71K€

Descripción del proyecto Medical product development is a lengthy and expensive process with limited success. After more than €40 million and over 10 years for clinical programmes, only 15% of new therapies reach the market. Many of the new therapies fail at the post-marketing phase due to unexpected side effects or insufficient efficacy. This is mainly because clinical trials focus on a narrow group of patients that do not represent the general patient population. Pharmaceutical and MedTech industries urgently need novel solutions to increase the efficiency and generalizability of clinical research programs. Benete is an information technology-oriented Finnish company that developed a Life Analytics Platform to provide high-quality, accurate, and reliable Real-World Evidence (RWE) to clinical trials. The Life Analytics Platform collects a novel source of real-life data to generate behaviour and functionality models of patients, combining ambient sensors with advanced artificial intelligence technology. Benete’s technology observes patients in their daily routines and identifies changes in their functioning in real life. This game-changing approach will provide medical product developers with invaluable insights into the efficacy and safety of a medical product in diverse patient populations, outside of the controlled environment of the clinic. The RWE data provided by Benete’s service will directly benefit clinical product development by 1- accelerating the timelines, 2- decreasing the overall costs, 3- increasing the predictive power, 4- supporting regulatory and reimbursement processes. Benete will use this SMEi phase1 funding to 1) assess the market requirements of its Life Analytics Platform by conducting a comprehensive market analysis and user involvement study, 2) identify strategic partners, and 3) establish IP and regulatory strategies. These activities will allow Benete to define the best commercialisation strategy for the Life Analytics Platform in the clinical trial market.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores